Hello. I see Abiraterone was approved today by the SMC in Scotland for high risk patients with metastatic hormone sensitive prostate cancer. The first drug to be approved in this indication of high unmet need. My English based Father (but with family roots in Scotland) has high risk mHSPC, so my question is...does he need to move to Scotland to get access to it? Would he have to buy or even rent? Give up his house in England?
The only alternatives I see to this (bar staying on ADT alone until becomes Castration resistant) would be to:
- Pay privately. Would be around £36k a year. Anyone paying privately for Abi? Or paying until it is hopefully then funded?
- Else wait and hope it is NICE approved soon for rx'ing in NHS England - but could ge a long wait!
- Wait and hope that Enzalutamide or Apalutamide get their mHSPC licenses soon for mHSPC, and also rx'd in NHS England
- Any other alternatives?
Thanks for thoughts, as really want best possible outcomes for my Father, who is also a carer himself, but would rather not use up all life savings, which I would happily do to help him live longer